| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.5 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.6 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |